Anti-CD19scFv-CD28-CD3ζ CAR engineered syngeneic T cells which target murine CD19 were adoptively transferred to immune competent mice which expressed CD19 on healthy B-cells and on a transplanted, syngeneic lymphoma. The gene discussed is CD19; the disease is lymphoma.